CLINICAL_TRIALS
trial_result
· 2013-04-09
Clinical Trial Update: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants [Phase 1]
Summary
Phase 1 interaction trial evaluating telaprevir (TMC435) with antidepressants in hepatitis C patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED